Sun et al. also showed that PDE7B was frequently downregulated in clear cell renal cell carcinoma (ccRCC) cells, which increased cell viability and migration, suggesting that PDE7B exerts anti-tumorigenic effects in cancers [17], consistent with our results. Here, PDE7B is linked to nonpapillary renal cell carcinoma.